Bio-Connect

Wnt16 antibody

GTX128468
GeneTex
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetWNT16
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Wnt16 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1.65 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID51384
  • Target name
    WNT16
  • Target description
    Wnt family member 16
  • Target synonyms
    protein Wnt-16; wingless-type MMTV integration site family member 16b; wingless-type MMTV integration site family, member 16
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9UBV4
  • Protein Name
    Protein Wnt-16
  • Scientific Description
    The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It contains two transcript variants diverging at the 5 termini. These two variants are proposed to be the products of separate promoters and not to be splice variants from a single promoter. They are differentially expressed in normal tissues, one of which (variant 2) is expressed at significant levels only in the pancreas, whereas another one (variant 1) is expressed more ubiquitously with highest levels in adult kidney, placenta, brain, heart, and spleen. [provided by RefSeq]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting. Karvonen H et al., 2019 Apr, Oncogene
    Read more
  • ERAD-dependent control of the Wnt secretory factor Evi. Glaeser K et al., 2018 Feb 15, EMBO J
    Read more
  • Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model. Aso E et al., 2016 Oct 4, J Alzheimers Dis
    Read more